BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10355740)

  • 1. Tumor-initiating activity of the (+)-(S,S)- and (-)-(R,R)- enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene in mouse skin.
    Luch A; Friesel H; Seidel A; Platt KL
    Cancer Lett; 1999 Mar; 136(2):119-28. PubMed ID: 10355740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells.
    Luch A; Seidel A; Glatt H; Platt KL
    Chem Res Toxicol; 1997 Oct; 10(10):1161-70. PubMed ID: 9348439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland.
    Cavalieri EL; Higginbotham S; RamaKrishna NV; Devanesan PD; Todorovic R; Rogan EG; Salmasi S
    Carcinogenesis; 1991 Oct; 12(10):1939-44. PubMed ID: 1934274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The level of DNA modification by (+)-syn-(11S,12R,13S,14R)- and (-)-anti-(11R,12S,13S,14R)-dihydrodiol epoxides of dibenzo[a,l]pyrene determined the effect on the proteins p53 and p21WAF1 in the human mammary carcinoma cell line MCF-7.
    Luch A; Kudla K; Seidel A; Doehmer J; Greim H; Baird WM
    Carcinogenesis; 1999 May; 20(5):859-65. PubMed ID: 10334204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenicity of four optically active bay-region 3,4-diol 1, 2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine on mouse skin and in newborn mice.
    Chang RL; Wood AW; Kumar S; Lehr RE; Shirai N; Jerina DM; Conney AH
    Carcinogenesis; 2000 Nov; 21(11):1997-2003. PubMed ID: 11062160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin.
    Higginbotham S; RamaKrishna NV; Johansson SL; Rogan EG; Cavalieri EL
    Carcinogenesis; 1993 May; 14(5):875-8. PubMed ID: 8504480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay.
    Ralston SL; Coffing SL; Seidel A; Luch A; Platt KL; Baird WM
    Chem Res Toxicol; 1997 Jun; 10(6):687-93. PubMed ID: 9208176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti (11R,12S,13S,14R)- and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7.
    Ralston SL; Seidel A; Luch A; Platt KL; Baird WM
    Carcinogenesis; 1995 Dec; 16(12):2899-907. PubMed ID: 8603462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenicity of racemic and optically pure bay region diol epoxides and other derivatives of the nitrogen heterocycle dibenz[a,h]acridine on mouse skin.
    Kumar S; Chang RL; Wood AW; Xie JG; Huang MT; Cui XX; Kole PL; Sikka HC; Balani SK; Conney AH; Jerina DM
    Carcinogenesis; 2001 Jun; 22(6):951-5. PubMed ID: 11375904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and tumor-initiating activity in mouse skin of dibenzo[a,l]pyrene syn- and anti-fjord-region diolepoxides.
    Gill HS; Kole PL; Wiley JC; Li KM; Higginbotham S; Rogan EG; Cavalieri EL
    Carcinogenesis; 1994 Nov; 15(11):2455-60. PubMed ID: 7955091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8,9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene is a potent morphological cell-transforming agent in C3H10T(1)/(2)Cl8 mouse embryo fibroblasts in the absence of detectable stable covalent DNA adducts.
    Nesnow S; Davis C; Padgett WT; Adams L; Yacopucci M; King LC
    Carcinogenesis; 2000 Jun; 21(6):1253-7. PubMed ID: 10837018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene.
    Luch A; Coffing SL; Tang YM; Schneider A; Soballa V; Greim H; Jefcoate CR; Seidel A; Greenlee WF; Baird WM; Doehmer J
    Chem Res Toxicol; 1998 Jun; 11(6):686-95. PubMed ID: 9625737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent DNA adducts formed in mouse epidermis by benzo[g]chrysene.
    Giles AS; Seidel A; Phillips DH
    Carcinogenesis; 1996 Jun; 17(6):1331-6. PubMed ID: 8681451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol.
    Platt KL; Dienes HP; Tommasone M; Luch A
    Chem Biol Interact; 2004 Jun; 148(1-2):27-36. PubMed ID: 15223354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P) or its metabolites and in rat mammary gland treated with DB[a,l]P.
    Cavalieri EL; Rogan EG; Li KM; Todorovic R; Ariese F; Jankowiak R; Grubor N; Small GJ
    Chem Res Toxicol; 2005 Jun; 18(6):976-83. PubMed ID: 15962932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of fjord region tetraols and their use in hepatic biotransformation studies of dihydrodiols of benzo[c]chrysene, benzo[g]chrysene and dibenzo[a,l]pyrene.
    Luch A; Platt KL; Seidel A
    Carcinogenesis; 1998 Apr; 19(4):639-48. PubMed ID: 9600349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations induced by (-)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo[a,l]pyrene in the coding region of the hypoxanthine phosphoribosyltransferase (Hprt) gene in Chinese hamster V79 cells.
    Mahadevan B; Dashwood WM; Luch A; Pecaj A; Doehmer J; Seidel A; Pereira C; Baird WM
    Environ Mol Mutagen; 2003; 41(2):131-9. PubMed ID: 12605383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and mutagenicity of the diastereomeric fjord-region 11,12-dihydrodiol 13,14-epoxides of dibenzo[a,l]pyrene.
    Luch A; Glatt H; Platt KL; Oesch F; Seidel A
    Carcinogenesis; 1994 Nov; 15(11):2507-16. PubMed ID: 7955100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the (-)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo.
    Mahadevan B; Luch A; Seidel A; Pelling JC; Baird WM
    Carcinogenesis; 2001 Jan; 22(1):161-9. PubMed ID: 11159755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.